Parenteral Drugs (India) has informed that pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, the Company enclosed Confirmation Certificate for dematerialization requests, cancellation of certificates and consequential actions, if any, as received from Link Intime India, RTA of the Company for the third quarter of the financial year 2020-21 ended on 31st December, 2020.
The above information is a part of company’s filings submitted to BSE.